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Women’s Clinical Preventive Services in the United States: Who 
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A well-woman preventive care visit is a core service supported by the Human Resources and 
Services Administration,1 yet it is unclear which preventive services are provided by 
primary care physicians (PCPs) and which are provided by obstetrician/gynecologists (OB/
GYNs).2,3 We examined patterns of selected age-appropriate preventive care visits across a 
woman’s lifespan, focusing on the wide range of preventive services provided to 
nonpregnant women.
Methods
The study was considered exempt for institutional review board approval by the Centers for 
Disease Control and Prevention because these were considered public use data and there 
were no identifiable data. We used abstracted data from medical records of national 
representative visits occurring from 2007 to 2010 to office-based physicians collected 
through the National Ambulatory Medical Care Survey (NAMCS) and visits to outpatient 
departments collected through the National Hospital Ambulatory Medical Care Survey 
(NHAMCS).4 The sample was limited to preventive care visits among nonpregnant women 
18 years or older (N = 14 075 visits). Applicable use of preventive services was determined 
using survey encounter forms; see the Table for complete listing and target population age. 
Since data collection for contraceptive care counseling was available only for 2009 to 2010, 
the estimates were excluded from our study.
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Visits to PCPs (family medicine and/or general practitioners and internists) and general 
medicine outpatient clinics were grouped to allow comparison with visits to office-based 
OB/GYNs and obstetrics/gynecology outpatient clinics. Data from the NAMCS and 
NHAMCS were weighted by inverse of selection probabilities, adjustment for nonresponse, 
and a population ratio adjustment to produce unbiased annual estimates. Data were 
combined and averaged across the 4 years of observation. Differences in estimates by 
specialty were evaluated by t tests (P < .05).
Results
From 2007 to 2010, an average of 281 406 600 medical visits occurred annually, of which 
22.4% (62 933 700) were for preventive care. Of these, 44.0% (27 712 300) were to OB/
GYNs and 56.0% (35 221 400) were to PCPs. Women 50 years or older had a higher 
percentage of preventive care visits to PCPs than younger women (P < .001) (Figure). 
Women 18 to 29 and 30 to 49 years old had the lowest percentages of preventive care visits 
to PCPs (41.2 and 45.0%; P < .001). A higher percentage of visits to OB/GYNs than visits 
to PCPs included screening for cervical cancer, breast cancer, Chlamydia, and osteoporosis 
(P < .05) (Table). Screening for colorectal cancer, cholesterol, diabetes mellitus, and 
counseling for diet, exercise, and obesity were more commonly provided during visits to 
PCPs (P < .01). About 82% of visits to OB/GYNs and 74% of visits to PCPs did not include 
counseling.
Discussion
Almost half of all women’s preventive care visits were to OB/GYNs, but these visits focused 
predominantly on reproductive health-related services. Visits to PCPs provided a wider 
range of services and higher volume of counseling, even among women of childbearing age. 
Thus, women of reproductive age who see OB/GYNs only for preventive care may not be 
receiving the full spectrum of recommended screening and counseling. Women aged 18 to 
49 years could be at increased risk for missing these services because women in this age 
group had the lowest percentage of visits to PCPs. The shift with age toward more 
preventive care visits to PCPs may increase receipt of general preventive health services; 
however, the overall provision of counseling services to either specialty was low. Because 
physicians have had little to no incentive in most payment systems to document counseling 
performed during clinic appointments, counseling services may have been underestimated. 
The Patient Protection and Affordable Care Act aims to increase access to insurance 
coverage for recommended clinical preventive services.5 Uptake of these services, however, 
may necessitate redefining the role of OB/GYNs and PCPs to coordinate and provide a full 
spectrum of recommended preventive services across the lifespan.
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Figure. US Preventive Care Visits by Nonpregnant Women 18 Years or Older, by Patient Age 
Group, and Clinician Specialty: NAMCS/NHAMCS, 2007 to 2010
Obstetrician/gynecologist (OB/GYN) includes visits to OB/GYN clinics and office-based 
OB/GYNs. Primary care physicians (PCPs) include visits to office-based internists, family 
medicine and/or general practitioners, and hospital general medical outpatient clinics. All 
differences in estimates were evaluated by t tests at the P < .05 level. Differences by 
specialty within patient age groups were significant. Weighted denominators were 62 933 
700 for all visits. Weighted denominators for patient age groups were as follows: 12 848 300 
for 18 to 29 years; 21 533 400 for 30 to 49 years; 16 694 400 for 50 to 64 years; 11 857 500 
for 65 years or older. NAMCS/NHAMCS indicates National Ambulatory Medical Care 
Survey/National Hospital Ambulatory Medical Care Survey.2
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Table
Preventive Care Visits by Nonpregnant Women 18 Years or Older That Included Age-Appropriate 
Recommendeda Screening and Counseling, by Specialty, NAMCS/NHAMCS, 2007 to 2010b
Type of Service
% P Values for Specialty 
DifferencesTotal OB-GYNs PCPs
Test and procedures
 Blood pressure screening 89.5 88.9 89.9 .56
 Cervical cancer screening with the Papanicolaou test alone, 21–64 y 39.4 56.2 23.0 <.001
 Cervical cancer screening with Papanicolaou test plus HPV testing, 30–64 y 3.6 5.8 1.7 .001
 Breast cancer screening with mammography with or without a clinical breast 
examination, ≥40 y
28.7 49.0 17.9 <.001
 Breast cancer screening with mammography alone, ≥40 y 8.6 9.2 8.2 .62
 Breast cancer screening with mammography and clinical breast examination, 
≥40 y
20.1 39.8 39.8 NA
 Colorectal cancer screening, 50–75 y 6.1 3.9 7.2 .01
 Cholesterol, ≥45 yc 25.2 5.4 34.5 <.001
 Cholesterol, 20–44c 11.9 3.0 24.3 <.001
 Diabetes 14.5 5.2 21.8 <.001
 Chlamydia testing, 18–24 y 12.3 15.3 8.0 .008
 Bone mineral density, ≥65 y 6.8 12.9 5.4 .01
 Depression 3.4 3.9 2.9 .47
Counseling
 Obesity 6.0 4.2 7.5 <.001
 Exercise 12.3 9.9 14.3 .005
 Diet 16.2 12.4 19.2 <.001
 Tobacco use or exposure 3.1 2.6 3.4 .16
 None of the 4 counseling services provided 77.0 81.5 73.5 .02
 ≥1 Counseling service provided 11.6 9.9 12.9 .001
 ≥2 Counseling services provided 11.4 8.6 13.6 <.001
Abbreviations: HPV, human papillomavirus; NA, not applicable; NAMCS/NHAMCS, National Ambulatory Medical Care Survey/National 
Hospital Ambulatory Medical Care Survey; OB/GYNs, obstetrician/gynecologists; PCPs, primary care physicians, family medicine and/or general 
practitioners, and internists.
a
Preventive services recommended for nonpregnant women by the US Preventive Services Task Force (USPSTF) specified in guidelines supported 
by the Health Resources and Services Administration.
b
Denominators vary depending on the age group for which each specific service is recommended.2
cSince screening for cholesterol abnormalities was a grade A USPSTF recommendation for women 45 years or older and a grade B USPSTF 
recommendation for women younger than 45 years, separate analyses were performed for each age group.
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